ABCL
AbCellera Biologics, Inc
Halal Rating :
See Details
Last Price
$3.26
Last updated:
Market Cap
$870.4m
7D Change
-2.9%
1 Year Change
-2.9%
Company Overview
Industries
Exchange
NASDAQ
Next Earnings Date
Feb. 20, 2024
AbCellera Biologics Inc. develops an antibody discovery platform. The company is headquartered in Vancouver, Canada.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| March 31, 2024 | $9.95m | $90.41m | $10.4m | - | 104.49% | 0.00% |
| Dec. 31, 2023 | $9.18m | $118.57m | $10.97m | $16.73m | 119.50% | 14.11% |
| Sept. 30, 2023 | $6.6m | $85.06m | $10.74m | - | 162.75% | 0.00% |
Company Impact
Help us evaluate AbCellera Biologics, Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.